We are live on
!
Find out more
SSP
Sixth Street Partners Portfolio holdings
AUM
$711M
1-Year Est. Return
9.3%
This Fund
S&P 500
This Quarter
Est. Return
-12.22%
1 Year Est. Return
-9.3%
3 Year Est. Return
+14.3%
5 Year Est. Return
+44.85%
10 Year Est. Return
–
AUM
$711M
AUM Growth
-$263M
(-27%)
Cap. Flow
-$96M
Cap. Flow
% of AUM
-13.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlanta Braves Holdings Series B
BATRK
|
+$33.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAI
Caris Life Sciences
CAI
|
+$109M |
| 2 |
PG&E
PCG
|
+$20.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.19% |
| 2 | Utilities | 33.64% |
| 3 | Financials | 10.31% |
| 4 | Communication Services | 9.34% |
| 5 | Consumer Discretionary | 5.74% |
Similar funds
DIA
LSIA
PCS
AMPWP
DCM
TLP
AC
DCM
Sixth Street Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Sixth Street Partners held 7 positions worth $711M, down 27% from $974M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Sixth Street Partners withdrew a net $96M in Q1 2026, reducing 2 holdings. Its largest reduction was Caris Life Sciences, cutting an estimated $109M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 54% a quarter earlier, followed by Utilities and Financials.
Against the trend, Sixth Street Partners added an estimated $33.7M to Atlanta Braves Holdings Series B.
- Sixth Street Partners added most to Atlanta Braves Holdings Series B in Q1 2026, an estimated $33.7M increase.
- Sixth Street Partners's biggest Q1 2026 reduction was Caris Life Sciences, cutting an estimated $109M.
- Sixth Street Partners's ten largest holdings make up 100% of its $711M portfolio in Q1 2026.
- Sixth Street Partners opened 0 new positions and closed 0 in Q1 2026.
- Sixth Street Partners's portfolio value fell 27% quarter-over-quarter to $711M.
Based on Sixth Street Partners's 13F filing for Q1 2026, filed 15 May 2026.